Fate Therapeutics

IPO

Public · La Jolla, United States · Founded 2007 · $30.0M raised

Employees
51–200
Founded
2007
Business Model
B2B
Total Funding
$30.0M
Last Round
$30.0M Series BNov 2009
Rounds
1
Type
Public

About

Clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies for autoimmune diseases and cancer.

Summary

Fate Therapeutics is a Biotech company based in La Jolla, United States, founded in 2007. It has raised $30.0M in total across 1 round, most recently a $30.0M Series B round in Nov 2009. Investors include OVP Venture Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketSecondary MarketMar 2024

Sign up to see all 4 rounds

Series B through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Fate Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/fate-therapeutics"><img src="https://indexed.vc/api/badge/company/fate-therapeutics" alt="Fate Therapeutics on Indexed.vc" width="260" height="76" /></a>